Review: Fructose, the Sweet Culprit behind Nonalcoholic Fatty Liver Disease and Type 2 Diabetes.
Level 5 - mechanism / opinion, no new human data
Narrative review without systematic methodology or primary human data
PubMed 40176716 · doi:10.2174/0115733998336827250114071627
What was done
This is a narrative review summarizing literature on the relationship between dietary fructose consumption, insulin resistance, nonalcoholic fatty liver disease (NAFLD), and type 2 diabetes mellitus (T2DM). The authors discuss shared metabolic pathways and risk stratification algorithms.
What was found
The abstract reports no primary experimental or statistical data, providing no effect sizes or patient counts. It qualitatively notes that dietary sugar consumption (specifically fructose) has increased more than tenfold in recent decades and describes how shared risk factors like obesity and insulin resistance link fructose intake to coexisting NAFLD and T2DM.
Why it matters
It outlines conceptual pathophysiological connections between high fructose intake and concurrent hepatic and metabolic disorders.
Limits
As a narrative review, it lacks a systematic search protocol, risk-of-bias evaluation, and quantitative synthesis. The abstract provides no primary data, participant numbers, or quantitative outcome measures.
Cited by
- partial Fructose is causing chronic liver disease in approximately 100 million Americans.